BIO Investor Forum: Bubble, boom or just robust; biotech financing's recent revival
This article was originally published in Scrip
Executive Summary
Biotechnology company executives are feeling pretty good about their chances of raising capital and health care investors seem to think they are some good opportunities to make money, since more than 30 drug developers have launched initial public offerings this year.